These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7360031)

  • 21. Genetic risk factors in the development of heart disease: familial hypercholesterolemia and hyperhomocysteinemia.
    LaCharity LA
    AACN Clin Issues; 1998 Nov; 9(4):531-8. PubMed ID: 9855863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary and drug treatment of severe hypercholesterolaemia.
    Lewis B
    Beitr Infusionsther; 1988; 23():39-46. PubMed ID: 2484781
    [No Abstract]   [Full Text] [Related]  

  • 23. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Daniels SR; Gidding SS; de Ferranti SD;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S30-7. PubMed ID: 21600527
    [No Abstract]   [Full Text] [Related]  

  • 24. Pseudo-homozygous type IIa hypercholesterolemia.
    Gupta M; Sharma RB; Parakh M
    Indian Pediatr; 1997 Aug; 34(8):734-7. PubMed ID: 9492405
    [No Abstract]   [Full Text] [Related]  

  • 25. Heterozygous Familial Hypercholesterolemia.
    Onorato A; Sturm AC
    Circulation; 2016 Apr; 133(14):e587-9. PubMed ID: 27045133
    [No Abstract]   [Full Text] [Related]  

  • 26. [Familial hypercholesterolemia: recognition and prevention of cardiac complications at a young age].
    Polak BC; Völker-Dieben HJ
    Ned Tijdschr Geneeskd; 2000 Sep; 144(37):1807. PubMed ID: 11004957
    [No Abstract]   [Full Text] [Related]  

  • 27. Bilateral middle ear cholesterol granuloma in familial hypercholesterolemia.
    Masaany M; Siti HS; Nurliza I; Mazita A
    Otolaryngol Head Neck Surg; 2008 Jun; 138(6):803-4. PubMed ID: 18503863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A genetic therapy for familial hypercholesterolemia.
    Dichek DA; Bratthauer GL; Beg ZH; Newman KD; Anderson KD; Zwiebel JA; Hoeg JM; Anderson WF
    Trans Assoc Am Physicians; 1990; 103():73-9. PubMed ID: 2132544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New pharmacologic treatments for familial hypercholesterolemia.
    McDonough A; Matura LA; Carroll D
    Nurs Womens Health; 2013 Oct; 17(5):443-7. PubMed ID: 24138664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xanthomas disappear rapidly after liver transplantation for familial hypercholesterolemia.
    Onaca N; Goldstein RM; Klintmalm GB
    Liver Transpl; 2003 Dec; 9(12):1334-5. PubMed ID: 14625835
    [No Abstract]   [Full Text] [Related]  

  • 31. Is there a problem with ezetimibe or just ENHANCEd hype?
    Whayne TF
    Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445
    [No Abstract]   [Full Text] [Related]  

  • 32. [The program for detection and treatment of patients with familial hypercholesterolemia (MedPed FH) in the Czech Republic].
    Freiberger T; Soska V; Kuhrová V; Stejskal J
    Cas Lek Cesk; 2000 Apr; 139(7):195-6. PubMed ID: 10916204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and treatment of familial hypercholesterolemia].
    Makino I
    Hokkaido Igaku Zasshi; 1992 Jul; 67(4):437-40. PubMed ID: 1427588
    [No Abstract]   [Full Text] [Related]  

  • 34. The application of molecular biology techniques to the diagnosis of hyperlipidaemia and other risk factors for cardio-vascular disease.
    Humphries SE
    Ann Biol Clin (Paris); 1994; 52(1):67-75. PubMed ID: 8210077
    [No Abstract]   [Full Text] [Related]  

  • 35. [Familial hypercholesterolemia: clinical aspects].
    Ciarrocchi A; Gaddi A; Rimondi S; Mezzetti M; Scaramuzzino G
    Cardiologia; 1988 Nov; 33(11):1055-60. PubMed ID: 3255492
    [No Abstract]   [Full Text] [Related]  

  • 36. [Familial hypercholesterolemia (clinical aspects, diagnosis, treatment)].
    Lopukhin IuM; Makrin SS
    Ter Arkh; 1983; 55(1):86-91. PubMed ID: 6836534
    [No Abstract]   [Full Text] [Related]  

  • 37. [Management of familial heterozygous hypercholesterolaemia. Position paper of the Polish Lipid Expert Forum].
    Rynkiewicz A; Cybulska B; Banach M; Filipiak KJ; Guzik T; Idzior Waluś B; Imiela J; Jankowski P; Kłosiewicz Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T;
    Kardiol Pol; 2013; 71(1):107-11. PubMed ID: 23348551
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular Disease, Atherosclerosis and Familial Hypercholesterolemia: From Molecular Mechanisms Causing Pathogenicity to New Therapeutic Approaches.
    Jebari-Benslaiman S; Larrea-Sebal A; Benito-Vicente A; Martín C
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Familial hypercholesterolemia: recognition and prevention of cardiac complications at a young age].
    Trip MD; Lansberg PJ; de Jongh S; Kastelein JJ
    Ned Tijdschr Geneeskd; 2000 Jul; 144(30):1425-8. PubMed ID: 10932693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association.
    Gidding SS; Champagne MA; de Ferranti SD; Defesche J; Ito MK; Knowles JW; McCrindle B; Raal F; Rader D; Santos RD; Lopes-Virella M; Watts GF; Wierzbicki AS;
    Circulation; 2015 Dec; 132(22):2167-92. PubMed ID: 26510694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.